INVESTIGATIONS
The results of various investigations are provided in Tables 1 to 6 . Her peripheral blood smear showed normocytic normochromic picture and hemolytic workup was negative [urine hemoglobin (Hb), plasma Hb, and glucose-6-phosphate dehydrogenase levels were normal]. Iron profile was within the range (ferritin 144, Serum Fe 91, TIBC 373). Viral markers [HBsAg and anti-hepatitis C virus (HCV)-negative] and autoimmune markers (ANA, ANCA, tTg) were also negative. Alfa fetoprotein (AFP) was also within the normal range (61 ng/mL).
Upper gastrointestinal endoscopy showed two columns of grade II esophageal varices. There was mild portal hypertensive gastropathy. X-ray chest showed bilateral symmetrical opacities with sparing of periphery. 
COURSE AND MANAGEMENT
A 61-year-old female, known case of type II DM, hypertension, NASH-related cirrhosis presented with complaints of altered sensorium since 2 days. On examination, patient had ascites and was in grade II HE. Laboratory parameters revealed anemia, thrombocytopenia, deranged renal and liver function tests, and coagulogram. Patient was managed with antibiotics, antihepatic coma measures, and albumin infusions. Patient's sensorium improved over the next 2 days; however, patient developed features of systemic inflammatory response syndrome (SIRS). Sepsis workup revealed normal procalcitonin, beta D-glucan, and galactomannan and sterile blood culture. However, urine culture grew yeast. After 1 day, patient developed sudden onset of breathlessness for which an emergency endotracheal intubation was done. Cardiology consultation was taken and the workup was suggestive of acute coronary syndrome with non-ST segment elevation myocardial infarction (NSTEMI). Patient sensorium worsened to grade III HE. In view of persistent SIRS and development of new onset of bilateral infiltrates on chest X-ray, antibiotics were upgraded from piperacillin-tazobactam to a combination of meropenem and teicoplanin. Patient also had high central venous pressure, metabolic acidosis, and elevated lactate and worsening creatinine for which she underwent sustained low-efficiency hemodialysis. In view of persistent SIRS, worsening sensorium and hemodynamic parameters, inotropes were started and fungal coverage with liposomal amphotericin B was initiated. Peritoneal dialysis was advised in view of worsening lactate and anuria; however, relatives did not give consent. Patient had cardiac arrest from which she could not be revived.
UNITS FINAL DIAGNOSIS
• Acute-on-chronic liver failure (ACLF):
-Acute: Sepsis (partially treated SBP) -Chronic: NASH-related cirrhosis of liver 
Syndromic Diagnosis
Acute-on-chronic liver failure: Two consensus working definitions exist for defining ACLF. The Asian Pacific Association for the Study of the Liver (APASL) defines ACLF as an acute hepatic insult manifesting as jaundice (serum bilirubin >5 mg/dL) (85 mol/L) and coagulopathy (International Normalized Ratio > 1.5 or prothrombin activity <40%) complicated within 4 weeks by clinical ascites and/or encephalopathy in a patient with previously diagnosed or undiagnosed chronic liver disease (CLD)/cirrhosis, and is associated with a high 28-day mortality. 1 The European Association for the Study of the Liver/ American Association for the Study of Liver Diseases defines ACLF as acute deterioration of preexisting CLD, usually related to a precipitating event and associated with increased mortality at 4 weeks to 3 months due to multisystem organ failure. Organ failure is a central component-hypothesize that organs behave differently to chronic decompensated liver disease.
Our patient would fit into ACLF by the European definition. 2 The imaging findings are suggestive of underlying cirrhosis while acute decompensated phase in the form of ascites and HE. Renal failure was also present as serum creatinine was raised (2.9 mg/dL) at presentation, which progressed to multiorgan failure in this patient.
Cause of Acute Deterioration
Sepsis could be an important cause as there was SBP and yeast growth on urine culture. Terminal pneumonia and disseminated intravascular coagulation could not be excluded as patient had high procalcitonin and total leukocyte count (TLC) with low fibrinogen and positive D-dimer. Infections can lead to high mortality in cirrhosis as Arvaniti et al showed that in patients with cirrhosis, infections increase mortality fourfold, with 30% of patients dying within 1 month after infection and another 30% die by 1 year. This is both for bacterial and fungal infections. 3 Since urine culture in our patient showed yeast growth, could fungal colonization be a provocating cause of death? Fungal "colonization" is associated with increased mortality in medical intensive care unit (ICU) patients with liver cirrhosis. Lahmer et al 4 analyzed the impact of fungal colonization on mortality of cirrhotic ICU patients. They retrospectively analyzed mortality analysis in 120 cirrhotic patients with and without fungal colonization. Out of 120 patients, 69 (58%) patients with cirrhosis had fungal colonization. These patients had significantly higher APACHE (Acute Physiology and Chronic Health Evaluation)-II score and mortality compared with cirrhotic patients without fungal colonization. They concluded that fungal "colonization" is independently associated with mortality in cirrhotic ICU patients. Early antimycotic therapy should be considered in critically ill cirrhotic patients with fungal colonization. A study done by Duseja et al 5 revealed nonhepatic insults are common acute precipitants in patients with ACLF. They studied 102 patients with ACLF, defined as per the APASL criteria, except for including the nonhepatic insults as precipitating events. Based on the type of acute insult, they were divided into type I (nonhepatic injury) and type II (hepatic injury-further divided into IIA-acute viral hepatitis on underlying CLD; IIB-other acute hepatic insults like drugs/toxins; and IIC-same disease responsible for worsening). They found 60% patients had type I ACLF, while 40% patients had type II ACLF. Infections were the most common nonhepatic causes of acute deterioration in type I ACLF, accounting for 47% cases. It was found that SBP alone accounts for 31%, almost one-third cases of acute deterioration in type I ACLF. A similar finding was reported by a Western study done by Jalan et al. 6 Could hepatocellular carcinoma (HCC) be a cause of acute deterioration? The answer is HCC can lead to acute worsening. Also, approximately 60 to 80% of cases of HCC are associated with cirrhosis. However, in our case there are no hepatic space-occupying lesions on USG. Viral markers are negative. In addition, AFP levels are not available. Noureddin et al 7 in an extensive review discussed the pathophysiologic mechanisms between obesity, insulin resistance, nonalcoholic fatty liver disease (NAFLD), and the progression to HCC, both in the presence and absence of cirrhosis. They showed that type II DM and/or obesity as a specific risk factor for HCC is highest (36.6%), followed by alcohol-related disorders (23.5%), HCV (22.4%), hepatitis B virus (6.3%), and rare genetic disorders (3.2%). So HCC could not be completely ruled out in this case.
Etiology of Cirrhosis
A simple diagram summarizing the various causes of cirrhosis is shown in Fig. 1 . Storage disorders, cardiovascular cause, and chronic biliary disease were not considered in this patient based on clinical and laboratory data. Chronic viral HCV and HBV are important cause of cirrhosis. The points in favor include as it is common cause of cirrhosis, age of presentation, and can present with decompensated liver disease. However, the points against include negative viral markers. However, occult HBV and HCV could not be ruled out since nucleic acid tests were not done in this case. Autoimmune hepatitis is another diagnosis in consideration. The points in favor include female and bimodal presentation of disease. The point against include negative autoimmune markers, no associated autoimmune diseases, and immunoglobulin G levels not available.
The patient had all the features of metabolic syndrome (Box 1). She was obese, hypertensive, diabetic, and had low high-density lipoprotein (HDL). So primary etiology of cirrhosis considered was NAFLD. A study by Duseja et al 8 showed that patients with cryptogenic cirrhosis or NAFLD have high BMI, high abdominal waist ratio, diabetes, and low HDL when compared with patients with viral cirrhosis. This case most likely fits with NASHrelated cirrhosis (Box 1).
Fig. 1: Etiologies of liver cirrhosis
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Cause of Renal Dysfunction in Cirrhosis
Spectrum of renal dysfunction in cirrhosis includes acute kidney injury (AKI), chronic kidney disease (CKD), and acute on CKD. Acute kidney injury is defined as rise in serum creatinine of >50% from baseline or a rise of serum creatinine by >0.3 mg/dL in <48 hours. Chronic kidney disease is defined as glomerular filtration rate (GFR) <60 mL/minute for >3 months calculated using Modification of Diet in Renal Disease (MDRD) formula. Acute on CKD is defined as rise in serum creatinine of >50% from baseline or a rise of serum creatinine by >0.3 mg/dL in <48 hours in a patient with cirrhosis whose GFR is <60 mL/minute for >3 months calculated using MDRD formula. Etiologies considered in this case included prerenal azotemia, hepatorenal syndrome (HRS)-AKI, non-HRS-AKI and septic acute tubular necrosis (ATN). The acute precipitating event would be HRS as the patient had all criteria for HRS except that kidney is slightly smaller. The septic ATN is favored as there was evidence of sepsis with the presence of SBP and also urine showed evidence of yeast growth. The only odd point against septic ATN was low urinary sodium which is more commonly seen in HRS rather than septic ATN. The cause of chronic renal dysfunction in this patient would be combination of nondiabetic kidney disease with diabetic nephropathy (DN). The odd point for DN is absence of proteinuria and small kidney with loss of corticomedullary distinction. There was no fundoscopic evidence of diabetic retinopathy (DR) and duration of diabetes <10 years. The point against nondiabetic kidney disease would be absence of significant history of kidney insults, such as analgesics and toxic agents. Just to have another differential diagnosis, NAFLD can be associated with CKD as they both share similar risk factor. A meta-analysis by Musso et al 9 showed that these patients have increased prevalence of CKD and some data of our unit (unpublished data) shows that patients irrespective of diabetes or HTN can have presence of microalbuminuria and mild reduction of GFR even in the absence of liver fibrosis or cirrhosis. Cause of anemia in this patient could be multifactorial-blood loss due to varices, portal hypertensive gastropathy, and hypersplenism. Further, these cirrhotic patients are also deficient in most of the nutrients like vitamin B12, folate, and iron. The terminal event in this patient is likely to be CAD, acute coronary syndrome, and NSTEMI. The points favoring CAD include sudden deterioration, Troponin I positive, and RWMA with EF of 30 to 35% on echo. A meta-analysis by Targher et al 10 showed that NAFLD is associated with fatal cardiovascular accident as well as nonfatal cardiovascular event as compared with normal population. The risk factor is much higher as compared with general population. The terminal event in this patient is multiple organ failure. European and North American cohort showed that in patients with ACLF, as the number of organ failure is increased, the mortality is increased. The data from our department also showed that the risk of mortality in ACLF increases as number of organ failure increases. 11, 12 So final diagnosis in this patient is ACLF (acute being sepsis precipitated by SBP, fungal urinary tract infection (UTI) and preterminally pneumonia; chronic being NASH-related cirrhosis), acute on CKD (acute being HRS or septic ATN; chronic being combination of nondiabetic CKD and DN). Cause of death is CAD with acute coronary syndrome and multiorgan failure with sepsis.
CLINICAL DISCUSSION
Prof Ajay Duseja:
Though not fitting into APASL criteria and bilirubin not touching 5 mg/dL, however, because of sudden deterioration in this case, ACLF should be considered. Acute precipitating events look like multiple infections. As bilirubin was not elevated, features of ACLF may not be seen on autopsy findings. Fat tends to disappear during the progression to cirrhosis in NAFLD.
Prof Subash Varma: What was bilirubin value during earlier admission?
Prof Ajay Duseja: Around 2 to 3 mg/dL. Dr Siddhartha (Senior Resident): Possibility of microangiopathic hemolytic anemia in background of uncontrolled hypertension needs to be considered as there is anemia and thrombocytopenia. However, there is normal peripheral blood smear and normal urine haptoglobin.
Prof Subash Varma: Rapidly progressive anemia is usually seen in microangiopathic hemolytic anemia. In this patient, anemia remained almost stable.
Prof Ajay Duseja: In HRS, usually there is normal kidney. Recently, type III HRS has been described, where HRS can be seen even in the presence of renal disease. Underlying kidney diseases in this patient are either related to NASH or diabetes, and acute event is related to ATN or HRS.
Prof Arunaloke Chakraborty: In ICU patients, yeast in urine usually indicates colonization.
Resident: Presence of chronic renal failure and chronic liver failure in this patient may be attributed to HCV infection which can cause polyarteritis nodosa or membranoproliferative glomerulonephritis pattern of renal injury. Dr Sunil Taneja: Viral markers are negative in this patient.
Prof Subash Varma: Cause of acute deterioration in this patient is sepsis or something else; ARDS and low EF due to sepsis or underlying myocardial disease needs to be clarified.
PATHOLOGY PROTOCOL BY DR VIKARN
A partial autopsy was performed. Peritoneal cavity yielded 2.5 L of straw-colored fluid. Pleural cavities each yielded 800 mL fluid. Pericardial cavity was within normal limits.
Liver: Weight-650 gm. Gross: Small, shrunken with varying sized nodules (2-6 mm) seen on capsular and cut surface. Extrahepatic biliary tree was patent and the portal vein did not show any thrombus. Microscopically, the liver showed distorted lobular architecture with porto-portal and porto-central bridging fibrosis and formation of both macronodules and micronodules. The septa showed minimal inflammation and occasional bile ductular proliferation. Increased collaterals were noted in the scarred parenchyma. Hepatocytes showed macrovesicular steatosis (amounting to 5-10% of area) in some of the nodules and glycogenation of the nuclei. Focal intracanalicular cholestasis was noted and some of the periseptal hepatocytes showed deposition of copper-associated protein (Orcein stain). Cytokeratin 7 immunostain highlighted the ductular proliferation and ductular metaplasia. Hepatitis B surface antigen and hepatitis B core antigen immunostains were negative (Fig. 2) .
Gall Bladder: It showed four gall stones, multifaceted with yellowish brown cut surface.
Spleen: Weight-320 gm. Mild splenomegaly was present and showed congested red pulp.
Pancreas: Grossly, no significant pathology was seen. Amyloid was identified in islets (Fig. 3) . Mild focal intralobular fibrosis and fat infiltration were seen.
Esophagus and stomach: Gastroesophageal junction showed congestion with prominent mucosal folds. Stomach mucosa showed congestion with loss of rugosity. An ulcer was noted in body-antral junction measuring 3 cm in largest dimension. Microscopically, prominent dilated and congested submucosal blood vessels were noted in the gastric fundus (Fig. 2F) . In addition, ulcerated areas showed scattered fungal hyphae (mucor) with angioinvasion (Fig. 4) .
Small and large intestine: Mucosal aspect was bile stained. Serosal aspect was dull. Microscopically, prominent dilated and congested blood vessels were seen in the submucosa.
Kidneys: (right, 130 gm and left, 80 gm) Right kidney is enlarged and appears swollen. Distinct corticomedullary distinction is noted. Left kidney is small compared with right and capsule is densely adherent. Cut surface shows indistinct corticomedullary distinction. A small impacted stone is noted in the lower minor calyx. Microscopically, both kidneys show changes of DN with the presence of Kimmelstiel-Wilson lesion (DN, class III). 13 Scattered patches of interstitial fibrosis and tubular atrophy are also seen. In addition, features of ATN are seen. Smaller left kidney shows scarred areas with thyroidization of tubules with sclerosed glomeruli, possibly due to arteriosclerosis with intimal thickening and multilayering of internal elastic lamina (Fig. 5) .
Lungs: Weight-1,120 gm. Heavy and showed diffuse consolidation. Microscopically, features of diffuse alveolar damage in the form of deposition of bright homogenous eosinophilic material were noted along the alveolar ducts (Fig. 6) .
Heart: Weight-300 gm. Mild left ventricular hypertrophy was noted. Coronaries were dissected out and mild narrowing of the lumen with atherosclerotic plaque was noted in left anterior descending artery. No coronary occlusion was noted. No infarct was seen (Fig. 7) .
Adrenal glands, bone marrow, urinary bladder, skeletal muscle: No significant patho logy seen. 
FINAL AUTOPSY DIAGNOSIS
In
FINAL DISCUSSION
Prof Ajay Duseja: Absence of myocardial infarction (MI) at autopsy is difficult to accept as the patient had NASH and features suggestive of MI on echo and ECG. Cardiovascular complications are important cause of mortality in these patients, rather than cirrhosis. Fat can cause various complications, such as myocardial steatosis or changes in the pericardium, which could lead to low EF in these patients. No intrinsic hepatic features of ACLF were present. There is possibility of septicemic hepatitis that could explain ACLF. Liver is small in this case, whereas usually in NASH-related cirrhosis there Prof Kim Vaiphei: Primary fungal infection of gastrointestinal tract should be considered when there is no underlying comorbid factor, such as diabetes, etc. Myocardium had changes of chronic ischemia as the picture shows fibrosis not edema. Anisonucleosis was present, which would be related to hypertrophy. Right ventricle examination needs to be done again for fat infiltration.
Prof Sanjay Jain: Diabetic nephropathy in absence of proteinuria is seen in 30% of cases. Diabetic nephropathy definition requires decrease in estimated GFR or presence of proteinuria or both. Nonproteinuric DN patients have more risk of cardiovascular mortality. Gastrointestinal mucormycosis needs to be documented as it is now wellknown route of entry other than respiratory. The terms "SIRS" and "severe sepsis" have been abandoned and are being replaced by sepsis and septic shock.
Prof Menu Singh: What is clinical correlation of finding amyloid in pancreas?
Prof Subash Varma: Amyloid deposits are seen in adult-onset DM. There is gross discrepancy in the pathological and radiological findings of kidneys regarding size.
Dr Anmol Bhatia: This could be observer dependent. Prof Subash Varma: Discrepancy in bed-side echo may be responsible cause for absence of MI in this case. T-wave inversion in single lead alone would be taken as diagnostic of MI.
Prof Arunaloke Chakraborty:
Lung is the primary route of infection of mycelium group of fungus. In case of mucor, organ-specific pathology has been shown. It can be rhinocerebral, pulmonary mucormycosis, abdominal, cutaneous, and disseminated variety.
Dr Nipun (senior resident): When should Candiduria be considered significant and when to suspect sepsis in the ICU patients. How to deal with beta-D-glucan-negative patients since its sensitivity is up to 85%. Trop-I could be present in renal failure and single-lead T wave inversion is seen.
Prof Sanjay Jain: For sepsis, there is worsening of Sequential Organ Failure Assessment score by 2. The infection should be considered significant if there is evidence of sepsis.
Dr Sunil Taneja: Regional wall motion abnormalities are quite specific for MI, although EF alone could be attributed to septicemia, so acute coronary syndrome was considered in this patient. Trop-I can be positive in renal failure. 
